← Back to all signals
RESEARCH PAPER ANALYSIS

Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

AI interpretation is pending for this paper.

Open original publication →
PMID39574153
JournalRadiation oncology (London, England)
Publication Date2024-11-21
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

INTRODUCTION: The delineation of organs-at-risk and lymph node areas is a crucial step in radiotherapy, but it is time-consuming and associated with substantial user-dependent variability in contouring. Artificial intelligence (AI) appears to be the solution to facilitate and standardize this work. The objective of this study is to compare eight available AI software programs in terms of technical aspects and accuracy for contouring organs-at-risk and lymph node areas with current international contouring recommendations. MATERIAL AND METHODS: From January-July 2023, we performed a blinded study of the contour scoring of the organs-at-risk and lymph node areas by eight self-contouring AI programs by 20 radiation oncologists. It was a single-center study conducted in radiation department at the Lorraine Cancer Institute. A qualitative analysis of technical characteristics of the different AI programs was also performed. Three adults (two women and one man) and three children (one girl and two boys) provided six whole-body anonymized CT scans, along with two other adult brain MRI scans. Using a scoring scale from 1 to 3 (best score), radiation oncologists blindly assessed the quality of contouring of organs-at-risk and lymph node areas of all scans and MRI data by the eight AI programs. We have chosen to define the threshold of an average score equal to or greater than 2 to characterize a high-performing AI software, meaning an AI with minimal to moderate corrections but usable in clinical routine. RESULTS: For adults CT scans: There were two AI programs for which the overall average quality score (that is, all areas tested for OARs and lymph nodes) was higher than 2.0: Limbus (overall average score = 2.03 (0.16)) and MVision (overall average score = 2.13 (0.19)). If we only consider OARs for adults, only Limbus, Therapanacea, MVision and Radformation have an average score above 2. For children CT scan, MVision was the only program to have a average score higher than 2 with overall average score = 2.07 (0.19). If we only consider OARs for children, only Limbus and MVision have an average score above 2. For brain MRIs: TheraPanacea was the only program with an average score over 2, for both brain delineation (2.75 (0.35)) and OARs (2.09 (0.19)). The comparative analysis of the technical aspects highlights the similarities and differences between the software. There is no difference in between senior radiation oncologist and residents for OARs contouring. CONCLUSION: For adult CT-scan, two AI programs on the market, MVision and Limbus, delineate most OARs and lymph nodes areas that are useful in clinical routine. For children CT-scan, only one IA, MVision, program is efficient. For adult brain MRI, Therapancea,only one AI program is efficient. TRIAL REGISTRATION: CNIL-MR0004 Number HDH434.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Serological Evaluation of Anti- FSH Antibody and Anti- LH antibody In Iraqi Women with Polycystic Ovarian Syndrome. F1000Research 62.66 2 Deaths: Leading Causes for 2024. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 57.5 3 Association between hematopoietic recovery indicators and minimal residual disease after induction therapy in newly diagnosed pediatric acute myeloid leukemia. Frontiers in medicine 64.74 4 Methylprednisolone sodium succinate combined with azithromycin in the treatment of Mycoplasma pneumonia in children and Its effect on immune function. Frontiers in pediatrics 67.54 5 Potential of isotoxic dose escalation with robustly optimized VMAT and IMPT for large hepatocellular carcinoma according to baseline liver function. Journal of applied clinical medical physics 80.42 6 Lifestyle Behaviors and Physical Health in Canadian Childhood, Adolescent, and Young Adult Cancer Survivors. Cancer medicine 58.7 7 Assessment of Selected Immunophenotypic Markers in Childhood Non-Hodgkin's Lymphomas in Ghana: A Possible Tool for Effective Stratification of Patients and Assessment of Survival Outcomes. Cancer reports (Hoboken, N.J.) 70.02 8 Establishing environmental causes of childhood cancer: a view from the IARC Monographs. UCL open. Environment 63.0 9 Chatbot Intervention and Cancer Risk Knowledge in Adolescents and Young Adults With Cancer Predisposition: A Randomized Clinical Trial. JAMA network open 73.7 10 Qualitative Exploration of Fertility-Related Attitudes and Perspectives Among Young Adult Women Diagnosed With Breast Cancer at Periurban Cancer Center in Uganda. JCO global oncology 61.1 11 Rare aetiologies of leg ulcers: a prospective analysis. Journal of wound care 65.8 12 Clinically actionable genetic findings by exome sequencing performed for therapeutic purposes in children with very-high risk cancer included the MAPPYACTS study. European journal of cancer (Oxford, England : 1990) 71.54 13 Rapid Whole Genome Sequencing Enhances Pediatric Cancer Diagnosis. Nature communications 66.6 14 Cardiopulmonary exercise testing to measure cardiorespiratory fitness in childhood cancer survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 47.5 15 Age- and latency-specific patterns of subsequent malignant brain and other nervous system tumors after cancer diagnosed before age 40 years. Cancer causes & control : CCC 56.0 16 Impact of Extent of Surgical Resection on Survival in Patients With High-risk Neuroblastoma: A Report From Children's Oncology Group ANBL0532. Annals of surgery 71.72 17 Routine Serologic Duffy Testing in Pediatric Oncology: Clinical Utility and Feasibility in a Single-Center Cohort. Pediatric blood & cancer 79.0 18 Exercise Capacity, Physical Activity, Fatigue, and Neurocognitive Function in Adult Survivors of Childhood Acute Lymphoblastic Leukemia. Pediatric blood & cancer 61.0 19 "We Cannot Talk as a Family": Complexities of Survivorship Communication Among Hispanic/Latino Young Adult Survivors of Childhood Cancer, Parents, and Clinicians. Pediatric blood & cancer 59.6 20 Textbook Outcome in Pediatric Nephroblastoma Surgery After Neoadjuvant Chemotherapy: Defining Standards, Introducing Near-Miss, and Predictors of Failure. Pediatric blood & cancer 73.54 21 Parents of Youth With Cancer Report on Their Psychosocial Care: iSTEPPP Survey Finds Alignment and Gaps With Standards. Pediatric blood & cancer 61.9 22 Skipping of Exon 38 in Neurofibromatosis Type 1 Gene Is Not a Pathogenic Variant. Pediatric blood & cancer 54.0 23 Evidence-Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource-Sensitive Recommendations for the Asian Continent. Pediatric blood & cancer 67.4 24 Obesity's Impact on Prognosis in Ph-Like Acute Lymphoblastic Leukemia. Pediatric blood & cancer 61.2 25 Occupation and Lymphoma Risk by Cell of Origin: A Nationwide Matched Case-Control Study in Thailand. Cancer prevention research (Philadelphia, Pa.) 69.0 26 Cardioneuromodulation for Recurrent Malignant Neurocardiogenic Syncope in Pediatric Patients: Results from a Tertiary Center. Pediatric cardiology 61.5 27 Invasive Pneumococcal Disease in Children: A Retrospective Three-Center Study in Zhejiang Province, China (2010-2024). Infectious diseases and therapy 66.1 28 Speciation-informed Bayesian assessment of metal(loid) exposure from Akora River fish, Ghana, for consumption guidance. Environmental monitoring and assessment 58.4 29 Clinical characteristics, anatomical distribution, and diagnostic patterns of simple bone cysts in Japan: an analysis of the Japanese Bone and Soft Tissue Tumor registry. International journal of clinical oncology 66.9 30 Pathological fracture as initial manifestation of malignancy and survival based on diagnoses: a register-based cohort study from the Swedish Fracture Register and the Swedish Cancer Register. Acta orthopaedica 66.52 31 Melanoma Prevention Among Children of Melanoma Survivors: A Randomized Clinical Trial. JAMA dermatology 78.0 32 Causal estimation and machine learning methods for survival outcomes among AYA cancer patients: A scoping review. Cancer epidemiology 67.02
PATIENT-FRIENDLY SUMMARY

Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic